Studies offer little hope for Tocilizumab in treating COVID

Studies offer little hope for tocilizumab in treating COVID – CIDRAP

See studies: Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19 – JAMA Internal Medicine AND Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial – JAMA Internal Medicine AND Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial – JAMA Internal Medicine

Commentary: expert reaction to three studies of Tocilizumab to treat COVID patients – Science Media Centre

Related study (preprint): Tocilizumab in Hospitalized Patients With COVID-19 Pneumonia – medRxiv